Shiro Takekawa

Fujisawa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Inhibition of MGAT2 modulates fat-induced gut peptide release and fat intake in normal mice and ameliorates obesity and diabetes in ob/ob mice fed on a high-fat diet.

Inhibition of MGAT2 modulates fat-induced gut peptide release and fat intake in normal mice and ameliorates obesity and diabetes in ob/ob mice fed on a high-fat diet.

Journal: FEBS open bio

Published: August 09, 2019

Antiobesity and emetic effects of a short-length peptide YY analog and its PEGylated and alkylated derivatives.

Antiobesity and emetic effects of a short-length peptide YY analog and its PEGylated and alkylated derivatives.

Journal: Bioorganic & medicinal chemistry

Published: September 23, 2017

Identification and Characterization of a New Series of Ghrelin O-Acyl Transferase Inhibitors.

Identification and Characterization of a New Series of Ghrelin O-Acyl Transferase Inhibitors.

Journal: SLAS discovery : advancing life sciences R & D

Published: August 29, 2017

A potent neuromedin U receptor 2-selective alkylated peptide.

A potent neuromedin U receptor 2-selective alkylated peptide.

Journal: Bioorganic & medicinal chemistry letters

Published: July 22, 2017

Highly potent antiobesity effect of a short-length peptide YY analog in mice.

Highly potent antiobesity effect of a short-length peptide YY analog in mice.

Journal: Bioorganic & medicinal chemistry

Published: July 14, 2017

Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide.

Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide.

Journal: Journal of medicinal chemistry

Published: June 29, 2017

Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice.

Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice.

Journal: British journal of pharmacology

Published: May 18, 2017

Potent antiobesity effect of a short-length peptide YY-analogue continuously administered in mice.

Potent antiobesity effect of a short-length peptide YY-analogue continuously administered in mice.

Journal: Bioorganic & medicinal chemistry letters

Published: May 09, 2017

A potent and selective natriuretic peptide receptor-3 blocker 11-mer peptide created by hybridization of musclin and atrial natriuretic peptide.

A potent and selective natriuretic peptide receptor-3 blocker 11-mer peptide created by hybridization of musclin and atrial natriuretic peptide.

Journal: Bioorganic & medicinal chemistry letters

Published: April 11, 2017

Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.

Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.

Journal: International journal of obesity (2005)

Published: March 15, 2017

A PEGylated analog of short-length Neuromedin U with potent anorectic and anti-obesity effects.

A PEGylated analog of short-length Neuromedin U with potent anorectic and anti-obesity effects.

Journal: Bioorganic & medicinal chemistry

Published: January 18, 2017

Discovery of an artificial peptide agonist to the fibroblast growth factor receptor 1c/βKlotho complex from random peptide T7 phage display.

Discovery of an artificial peptide agonist to the fibroblast growth factor receptor 1c/βKlotho complex from random peptide T7 phage display.

Journal: Biochemical and biophysical research communications

Published: September 27, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026